U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Risk Evaluation and Mitigation Strategies | REMS
  5. REMS Compliance Program
  1. Risk Evaluation and Mitigation Strategies | REMS

REMS Compliance Program

FDA conducts inspections to evaluate compliance with risk evaluation and mitigation strategies (REMS) requirements to ensure the drug’s health benefits outweigh the risks for patients. Inspections are prioritized using a risk-based approach.

The agency will take action if issues found during the REMS inspections are not promptly and adequately corrected. Failure to comply with REMS requirements may result in enforcement action such as product seizure, injunction or civil money penalties.

FDA also reviews REMS assessment reports to evaluate compliance with legal and regulatory requirements. The agency takes appropriate regulatory action for noncompliance, which may include warning letters or untitled letters, to address serious safety concerns and mitigate risks to patients.

Contact CDER-OSI-REMS@fda.hhs.gov with questions about REMS compliance.

Additional resources




Back to Top